Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility

Rare, inherited mutations account for 5% to 10% of all prostate cancer cases. However, to date, few causative mutations have been identified. To identify rare mutations for prostate cancer, we conducted whole-exome sequencing (WES) in multiple kindreds (n = 91) from 19 hereditary prostate cancer (HP...

Ausführliche Beschreibung